Yonjin Capital
Cambridge, Massachusettsyjventure.com
Overview
Yonjin Capital LLC is the North America and Europe investment arm of Yongjin Group and the sister firm of Yonghua Capital, both based in China with headquarters in Shanghai. Yonjin Venture LLC specializes in early- and mid-stage life science companies. We are interested in innovative technologies in therapeutics, diagnostics and medical devices.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Rapafusyn Pharmaceuticals | Sep 2025 | Series A | Lead |
| HistoSonics | Aug 2025 | Buyout/LBO | Co-investor |
| TECLens, Inc. | Feb 2025 | Series A | Lead |
| HistoSonics | Aug 2024 | Series D | Co-investor |
| Spear Bio | Jul 2024 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
